Bioburden Testing Market Future Outlook with Rising Demand for Sterility Assurance in Pharmaceutical
The Bioburden Testing Market is projected to witness significant growth through 2034, driven by the rising demand for sterility assurance in pharmaceutical and medical device manufacturing. Bioburden testing has become an essential quality control procedure for determining the number and type of viable microorganisms present on raw materials, finished products, manufacturing equipment, packaging materials, and production environments. As regulatory agencies worldwide continue enforcing stringent
